Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP). To investigate the efficacy and safety of the IVIG IgPro10 (Privigen) for treatment of CIDP, results from Privigen Impact on Mobility and Autonomy (PRIMA), a prospective, open‐label...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Peripher Nerv Syst
Main Authors: Merkies, Ingemar S.J., van Schaik, Ivo N., Léger, Jean‐Marc, Bril, Vera, van Geloven, Nan, Hartung, Hans‐Peter, Lewis, Richard A., Sobue, Gen, Lawo, John‐Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2019
Assuntos:
Research Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594229/
https://ncbi.nlm.nih.gov/pubmed/30672091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jns.12302
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados